Sulfuric Acid

Sulfuric Acid

SCHEMBL1354089

O.O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].[O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5].[V+5].[V+5]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL4864252 1.00 MEN1 (0.39) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL1355412 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL2357738 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL2357736 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL28554884 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL25265024 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL6849522 0.89 ALDH1A1 (0.50) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL19858895 0.89 MEN1 (0.39) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL668306 0.89
Sulfuric Acid SCHEMBL7609386 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12095059-B2 Thermal barrier components including hydrates for mitigating thermal runaway in batteries GM Global Technology Operations LLC (US) 2024-09-17 US claimed
US-20230087207-A1 THERMAL BARRIER COMPONENTS INCLUDING HYDRATES FOR MITIGATING THERMAL RUNAWAY IN BATTERIES GM Global Technology Operations LLC (US) 2023-03-23 US claimed
US-9725530-B2 Supported metal oxide double active center polyethylene catalyst, process for preparing the same and use thereof EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2017-08-08 US claimed
US-9611339-B2 Supported double center hybrid polyethylene catalyst, process for preparing the same and use thereof EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2017-04-04 US claimed
US-20150080540-A1 NOVEL SUPPORTED DOUBLE CENTER HYBRID POLYETHYLENE CATALYST, PROCESS FOR PREPARING THE SAME AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2015-03-19 US claimed
US-20150065667-A1 SUPPORTED METAL OXIDE DOUBLE ACTIVE CENTER POLYETHYLENE CATALYST, PROCESS FOR PREPARING THE SAME AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2015-03-05 US claimed
US-12594465-B2 Golf balls having increased impact durability ACUSHNET COMPANY (US) 2026-04-07 US disclosed
US-20260077244-A1 GOLF BALLS HAVING CORE LAYERS WITH INDIVIDUAL HARDNESS GRADIENTS ACUSHNET COMPANY (US) 2026-03-19 US disclosed
US-12478840-B2 Golf balls having core layers with individual hardness gradients ACUSHNET COMPANY (US) 2025-11-25 US disclosed
US-20250312657-A1 GOLF BALLS HAVING CORES WITH INCREASED HARDNESS GRADIENT ACUSHNET COMPANY (US) 2025-10-09 US disclosed
US-20250303236-A1 HIGH HARDNESS GRADIENT GOLF BALL CORES AND METHODS OF MAKING SAME ACUSHNET COMPANY (US) 2025-10-02 US disclosed
US-12397202-B2 Golf ball with increased core hardness gradient and reduced spin ACUSHNET COMPANY (US) 2025-08-26 US disclosed
US-12337213-B2 Golf balls having cores with increased hardness gradient ACUSHNET COMPANY (US) 2025-06-24 US disclosed
US-9611339-B2 Supported double center hybrid polyethylene catalyst, process for preparing the same and use thereof EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2017-04-04 US disclosed
CN-105885681-A Polysilanyl thin film coating and preparation method thereof 铜陵方正塑业科技有限公司 2016-08-24 CN disclosed
US-20150372331-A1 HIGH-CONCENTRATION VANADIUM ELECTROLYTIC SOLUTION, AND METHOD AND DEVICE FOR PRODUCING THE SAME GALAXY CO., LTD (JP) 2015-12-24 US disclosed
EP-2958176-A1 HIGH-CONCENTRATION VANADIUM ELECTROLYTE, AND METHOD AND APPARATUS FOR PRODUCING SAME Galaxy Co., Ltd. (JP) 2015-12-23 EP disclosed
US-20150080540-A1 NOVEL SUPPORTED DOUBLE CENTER HYBRID POLYETHYLENE CATALYST, PROCESS FOR PREPARING THE SAME AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2015-03-19 US disclosed
US-20150065667-A1 SUPPORTED METAL OXIDE DOUBLE ACTIVE CENTER POLYETHYLENE CATALYST, PROCESS FOR PREPARING THE SAME AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2015-03-05 US disclosed
US-20110284809-A1 PARTICLES, METHOD OF PRODUCING PARTICLES, AND COATING MATERIAL, FILM, AND INK INCLUDING PARTICLES NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12594465-B2 Golf balls having increased impact durability PGR, LBR, PTGDR MEN1 4649/4885ALDH1A1 1239/4885TSHR 313/4885
US-20260077244-A1 GOLF BALLS HAVING CORE LAYERS WITH INDIVIDUAL HARDNESS GRADIENTS SHH, SOD1, ATP2A3 MEN1 3850/4885ALDH1A1 1595/4885TSHR 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.